Bücher online kaufen
Azilsartan vs Telmisartan - Which is better for raised Blood Pressure?
-0 %
Paperback
Print on Demand | Lieferzeit: Print on Demand - Lieferbar innerhalb von 3-5 Werktagen I
Artikel-Nr:
9786139986071
Veröffentl:
2019
Einband:
Paperback
Erscheinungsdatum:
07.02.2019
Seiten:
96
Autor:
Megha Garg
Gewicht:
161 g
Format:
220x150x6 mm
Sprache:
Englisch
Beschreibung:
Garg, Megha
Ms. Megha Garg is pursuing her Doctor of Pharmacy degree from Teerthanker Mahaveer University, Moradabad (U.P.) India. She was awarded as young medical achiever 2018 and best intern of the year 2018 (IHP awards, Goa). She is an author/ co-author in various research articles published in National/ International journals.
Ms. Megha Garg is pursuing her Doctor of Pharmacy degree from Teerthanker Mahaveer University, Moradabad (U.P.) India. She was awarded as young medical achiever 2018 and best intern of the year 2018 (IHP awards, Goa). She is an author/ co-author in various research articles published in National/ International journals.
As per the 2017 American College of Cardiology and American Heart Association guidelines, a blood pressure 130/80 mmHg is considered as hypertension. Ambulatory Blood Pressure Monitoring (ABPM) provides automated measurements of blood pressure over a 24-hour period while patients are engaging in their usual activities. Angiotensin Receptor Blockers (ARBs) inhibit the action of angiotensin II by binding directly to angiotensin 1 receptor and are most tolerated. Various studies have evaluated the efficacy and safety profile of Azilsartan medoxomil (AZL-M) and Telmisartan (TEL) in comparison to other ARBs or Angiotensin Converting Enzyme Inhibitors. Aim of this study was evaluate the efficacy and safety of Azilsartan medoxomil versus Telmisartan using Ambulatory Blood Pressure Monitoring, in approved doses.